Executive Functioning in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure

Sharon L Nichols1, Miriam C Chernoff2, Kathleen M Malee3

  • 1Department of Neurosciences, University of California, San Diego, La Jolla.

Insights

Children and adolescents with perinatally acquired HIV (PHIV) and a history of AIDS-defining conditions showed poorer executive functions (EFs). These findings highlight the impact of disease severity on cognitive development in youth with PHIV.

Area of Science:

  • Neuroscience
  • Pediatric HIV Research
  • Cognitive Psychology

Background:

  • Executive functions (EFs) are vital for daily life management.
  • Children and adolescents with perinatally acquired HIV (PHIV) are at risk for academic, behavioral, and adherence challenges.
  • Limited research exists on EFs in youth with PHIV.

Purpose of the Study:

  • To compare executive functions (EFs) in youth with PHIV and perinatally HIV-exposed but uninfected (PHEU) youth.
  • To investigate the impact of disease severity on EFs in youth with PHIV.

Main Methods:

  • Utilized four Delis-Kaplan Executive Function System (D-KEFS) subtests.
  • Administered to 173 youth with PHIV and 85 PHEU youth (aged 9 to <19 years) within the Pediatric HIV/AIDS Cohort Study (PHACS).
  • Compared youth with PHIV (with and without history of AIDS-defining conditions) to PHEU youth; analyzed associations with disease severity measures.

Main Results:

  • Youth with PHIV and a history of AIDS-defining conditions (PHIV/C) exhibited significantly slower performance and more errors on specific D-KEFS subtests compared to PHIV/non-C and PHEU groups.
  • No significant differences in fluency or problem-solving were found between groups.
  • Observed associations between specific EF measures and HIV RNA viral load, CD4 percentage, and age at greatest disease severity.

Conclusions:

  • Youth with PHIV and prior AIDS-defining conditions demonstrated deficits in certain executive function measures.
  • Further research is needed to understand the relationship between EF development and the degree/timing of HIV disease severity.
  • Findings have implications for long-term outcomes and the development of interventions for youth with PHIV.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
689
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306